Skip to main content
. 2016 Nov 7;2016:1454026. doi: 10.1155/2016/1454026

Table 2.

Published evidence on the use of SILS in pancreatic resectional surgery.

Procedure (number) Indication (number) Size of lesion (mm) (median and range) or (mean ± SD) Conversion rate (%) Operative time (min) (median and range) or (mean ± SD) Blood loss (mL) (median and range) or (mean ± SD) LOS (days) (median and range) or (mean ± SD) Complications (number)
Barbaros et al., 2010 [2] DP+S (1) RCC metastases (2) 23 (15–30) 0 330 100 7 POPF grade A (1)

Chang et al., 2012 [32] DP (1) SCN (1) 35 0 233 <100 3 None

Haugvik et al., 2013 [33] DP (5)
DP+S (3)
5 NET (5)
SCN (1)
IPMN (1)
Fibrosis (1)
21 (10–45) 0 145 (98–223) 225 (30–400) 6 (3–15) Port site infection (1)
Port site bleeding (1)
POPF grade B (2)

Machado et al., 2015 [34] DP (18)
DP+S (2)
NET (11)
IPMN (6)
MCN (3)
31 (9–70) 0 176 (110–340) <50 (<50–250) 2 (1–5) POPF grade A (4)

Misawa et al., 2012 [35] DP (1) Cystadenoma (1) 50 (35–65) 0 240 0 7 None
DP+S (1) MCN (1) 0 225 100 5 None

Ryan et al., 2015 [36] DP+S (16) PDA (3)
NET (2)
IPMN (2)
SCN (2)
MCN (1)
Splenunculi (1)
Splenic HM (1)
38 ± 30 (8–117) 19 190 (197 ± 40.7) 150 (246 ± 263.9) 4 (6 ± 3.8) AF (1)
Pneumonia (1)
Colonic abscess (1)

Srikanth et al., 2013 [37] DP+S (1) NET (1) 35 0 5 Collection (1)

Yao et al., 2014 [38] DP+S (7)
DP (7)
MCN (6)
SCN (3)
Pancreatic cysts (3)
Splenic artery aneurysm (2)
43 ± 22 (12–110) 7 166 ± 55 157 ± 162 7 ± 1 (5–10) POPF grade A/B (1)

Zhang et al., 2015 [39] Local excision (2)
DP (1)
Pancreatoblastoma (1)
Nesidioblastosis (2)
0 153 (120–200) Minimal 6-7 None

DP: distal pancreatectomy, DP+S: distal pancreatectomy and splenectomy, NET: neuroendocrine tumour, IPMN: intraductal papillary mucinous neoplasm, SCN: serous cystic neoplasm, MCN, mucinous cystic neoplasm, PDA: pancreatic ductal adenocarcinoma, HM: haemangioma, AF: atrial fibrillation, POPF: postoperative pancreatic fistula.